WeCure Pharma Nordic ApS — Credit Rating and Financial Key Figures

CVR number: 41349751
Slotsmarken 18, 2970 Hørsholm

Income statement (kDKK)

2020
2021
2022
Fiscal period length121212
Net sales
Gross profit-6.735.5015.44
EBIT-6.735.5015.44
Other financial expenses-0.14-1.17-0.38
Pre-tax profit-6.874.3415.06
Income taxes-0.46-3.32
Net earnings-6.873.8811.74

Assets (kDKK)

2020
2021
2022
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors17.2112.85
Short term receivables total17.2112.85
Cash and bank deposits29.5631.2258.73
Cash and cash equivalents29.5631.2258.73
Balance sheet total (assets)46.7744.0758.73

Equity and liabilities (kDKK)

2020
2021
2022
Share capital40.0040.0040.00
Retained earnings-6.87-3.00
Profit of the financial year-6.873.8811.74
Shareholders equity total33.1337.0048.74
Non-current liabilities total
Current trade creditors13.505.005.00
Short-term deferred tax liabilities0.463.32
Other non-interest bearing current liabilities0.141.601.66
Current liabilities total13.657.069.98
Balance sheet total (liabilities)46.7744.0758.73
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.